SL Bio, Horizon Space Acquisition II close business combination, to list as SL Science on Nasdaq

Horizon Space Acquisition II Corp.

Horizon Space Acquisition II Corp.

HSPT

0.00
  • SL Bio closed its business combination with Horizon Space Acquisition II, creating Cayman Islands holding company SL Science Holding.
  • SL Science ordinary shares expected to begin trading on Nasdaq Global Market on June 15 under ticker SLBT.
  • Deal implied SL Bio equity valuation of about USD 5.57 billion; transaction included a concurrent USD 7.8 million PIPE financing.
  • Proceeds aimed at advancing gamma delta T cell “off-the-shelf” therapies for solid tumors, with planned trials in pancreatic and brain cancers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Horizon Space Acquisition II Corp. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606121451PRIMZONEFULLFEED9746352) on June 12, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.